Carrico Thomas Joeseph 4
Research Summary
AI-generated summary
Neuraxis (NRXS) CRO Thomas Carrico Receives RSU Award
What Happened
Thomas Carrico (CRO, CCO, CPO) was granted 47,569 restricted stock units (RSUs) on 2026-01-22 as compensation. The grant is reported at a per-share value of $4.63, totaling $220,244. This was an award (not an open-market purchase or sale) and represents a derivative compensation grant rather than an immediate change in tradable shares.
Key Details
- Transaction date: 2026-01-22; Form 4 filed 2026-02-26 (filed 35 days after the grant — outside the typical 2-business-day Form 4 window).
- Grant: 47,569 RSUs valued at $4.63 each; total reported value $220,244. (Transaction code: A — Award/Grant/Other acquisition)
- Shares owned after transaction: Not specified in the filing.
- Footnote: RSUs were granted under the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan; they vest in three equal annual installments over three years.
- Filing timeliness: The Form 4 was filed late relative to the standard two-business-day reporting requirement.
Context
RSUs are a form of deferred compensation that convert into common stock only as they vest and typically remain subject to transfer restrictions until then; this grant does not represent a market purchase or sale. Such awards are common for executives and are intended as compensation or retention incentives rather than direct signals to buy or sell stock.